Biocan NOVEL canine vaccine range entering the Indian Market

Homepage News What´s new? Biocan NOVEL canine vaccine range entering the Indian Market

5.9.2024

Bioveta, a.s. is pleased to announce its partnership with a new partner in the Indian market. Together with Vetina Healthcare LLP, we are launching the one-decade-proven Biocan NOVEL vaccine range.

Vetina Healthcare LLP delivers innovative solutions for companion animals, including pharmaceuticals, nutrition, and insurance, to the Indian market. Their services also include distribution to end-users and veterinarians.

Biocan NOVEL vaccines offer protection against lethal canine infections. Together, we will enable more pets worldwide to benefit from reliable protection against infectious diseases that threaten their well-being. Furthermore, diseases like rabies and leptospirosis pose significant risks to entire communities, including humans. Regular vaccination of dogs against these diseases reduces the risk of infection in dogs and other animals, including humans and children.

We greatly appreciate the trust of this dynamic and rapidly growing company, which will exclusively deliver Biocan NOVEL to Indian veterinarians as a proven solution for their clientele. Biocan NOVEL is a versatile vaccine suitable for dogs of all breeds and lifestyles, providing peace of mind even for the most demanding pet owners.